Fresenius SE & Co. KGaA (ETR:FRE)
Germany
· Delayed Price · Currency is EUR 41.41
-0.57 (-1.36%)
Jul 15, 2025, 5:35 PM CET
Fresenius SE & Co. KGaA Revenue
Fresenius SE & Co. KGaA had revenue of 5.65B EUR in the quarter ending March 31, 2025, with 5.63% growth. This brings the company's revenue in the last twelve months to 22.13B, up 4.61% year-over-year. In the year 2024, Fresenius SE & Co. KGaA had annual revenue of 21.83B with 3.64% growth.
Revenue (ttm)
22.13B
Revenue Growth
+4.61%
P/S Ratio
1.05
Revenue / Employee
126.33K
Employees
176,486
Market Cap
23.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.83B | 766.00M | 3.64% |
| Dec 31, 2023 | 21.07B | -465.00M | -2.16% |
| Dec 31, 2022 | 21.53B | -15.99B | -42.61% |
| Dec 31, 2021 | 37.52B | 1.24B | 3.43% |
| Dec 31, 2020 | 36.28B | 868.00M | 2.45% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Siemens Healthineers AG | 23.14B |
| Merck KGaA | 21.32B |
| Bayer Aktiengesellschaft | 46.58B |
| Fresenius Medical Care AG | 19.49B |
| Sartorius Aktiengesellschaft | 3.44B |
| Fielmann Group AG | 2.33B |
| Carl Zeiss Meditec AG | 2.17B |
| SCHOTT Pharma AG & Co. KGaA | 972.81M |
Fresenius SE & Co. KGaA News
- 11 days ago - EQS-PVR: Fresenius SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 5 weeks ago - Fresenius: Healthy Portfolio Add - Seeking Alpha
- 2 months ago - Fresenius medical care outlines 2025 operating income growth targets amid strategic transformations - Seeking Alpha
- 2 months ago - Fresenius SE & Co. KGaA 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Fresenius SE & Co. KGaA (FSNUF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Fresenius SE & Co. KGaA reports Q1 results - Seeking Alpha
- 2 months ago - Fresenius posts profit beat in first quarter, confirms outlook - Reuters
- 2 months ago - Fresenius: Holding On For Longer-Term Growth Driven By Demand In Kidney Care Segment - Seeking Alpha